T-lymphocyte reconstitution following rigorously T-cell-depleted versus unmodified autologous stem cell transplants

Bone Marrow Transplantation

Volumn 37, Issue 8, 2006, Pages 763-772

  te Boekhorst, P A W ^a   Lamers, C H J ^a   Schipperus, M R ^b   Hintzen, R Q ^a   van der Holt, B ^a   Cornelissen, J J ^a   Lowenberg B ^a   Gratama, J W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b HAGA Hospitals ^*  (Netherlands)

Author keywords

Autologous stem cell transplantation; Immune reconstitution; T lymphocytes; T cell depletion

Indexed keywords

CD27 ANTIGEN; CD4 ANTIGEN; CD45RO ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FAS ANTIGEN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 2; MESNA; PADGEM PROTEIN; PROCARBAZINE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; AUTOGRAFT; AUTOLOGOUS STEM CELL TRANSPLANTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL REGENERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; FEMALE; GRAFT INFECTION; GRAFT REJECTION; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; IN VIVO STUDY; INTERMETHOD COMPARISON; LYMPHOCYTE SUBPOPULATION; MALE; MEMORY CELL; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; MULTIPLE SCLEROSIS; NEUTROPENIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADULT; ANTIGENS, CD27; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD45; ANTIGENS, CD95; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; HUMANS; IMMUNE SYSTEM; INTERFERON TYPE II; INTERLEUKIN-2; KINETICS; L-SELECTIN; LYMPHOCYTES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUTROPHILS; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 33645717081     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705333     Document Type: Article

References (40)

1. Van Gelder M, Kinwel-Bohre EP, Van Bekkum DW. Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT. Bone Marrow Transplant 1993; 11: 233-241.
2. Karussis DM, Vourka-Karussis U, Mizrachi-Koll R, Abramsky O. Acute/ relapsing experimental autoimmune encephalomyelitis: Introduction of long lasting, antigen-specific tolerance by syngeneic bone marrow transplantation. Multiple Sclerosis 1999; 5: 17-21.
3. Traynor AE, Schroeder J, Rosa RM, Cheng D, Stefka J, Mujais S et al. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: A phase I study. Lancet 2000; 356: 701-707.
4. Openshaw H, Nash RA, McSweeney PA. High-dose immunosuppression and hemopoietic stem cell transplantation in autoimmune diseases: Clinical review. Biol Blood Marrow Transplant 2002; 8: 223-248.
5. Nash RA, Bowen JD, McSweeney PA, Pavletic SZ, Maravilla KR, Park MS et al. High-dose immunosuppressive therapy and autologous stem cell transplantation for severe multiple sclerosis. Blood 2003; 102: 2364-2372.
6. Samijn JPA, Te Boekhorst PAW, Mondria T, Van Doorn PA, Flach HZ, van der Meché FG et al. Intense T-cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis. J Neurol Neurosurg Psychiatry 2006; 77: 46-50.
7. Guillaume T, Rubinstein DB, Symann M. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood 1998; 92: 1471-1490.
8. + hematopoietic progenitors. Blood 1998; 91: 2588-2600.
9. + selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma. Blood 1999; 93: 1858-1868.
10. + cells: Analysis of predictive factors and comparison with unselected progenitor transplants. Br J Haematol 2000; 108: 105-115.
11. Douek DC, Vescio RA, Betts MR, Brenchley JM, Hill BJ, Zhang L et al. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 2000; 355: 1875-1881.
12. +-enriched versus non-T cell-depleted autologous peripheral blood stem cell transplantation. J Hematother Stem Cell Res 2000; 9: 727-736.
13. +-selected versus unmanipulated autologous stem cell transplantation in multiple myeloma: Impact on dendritic and immune recovery and on complications due to infections. Ann Oncol 2003; 14: 475-480.
14. + selection and age. Blood 2003; 101: 1891-1897.
15. Storek J, Zhao Z, Lin E, Berger T, McSweeney PA, Nash RA et al. Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases). Clin Immunol 2004; 113: 285-298.
16. Muraro PA, Douek DC, Packer A, Chung K, Guenaga FJ, Cassiani-Ingoni R et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 2005; 201: 805-816.
17. + hematopoietic stem and progenitor cells. Curr Prot Cytometry 2003, 6.4.1-6.4.25.
18. Schnizlein-Bick CT, Spritzler J, Wilkening CL, Nicholson JK, O'Gorman MR. Evaluation of TruCount absolute-count tubes for determining CD4 and CD8 cell numbers in human immunodeficiency virus-positive adults. Site Investigators and The NIAID DAIDS New Technologies Evaluation Group. Clin Diag Lab Immunol 2000; 7: 336-343.
19. Glencross D, Scott LE, Jani IV, Barnett D, Janossy G. CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration. Cytometry 2002; 15: 69-77.
20. Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708-712.
21. + T cell population. J Immunol 1995; 154: 17-25.
22. Gratama JW, Van Esser JWJ, Lamers CHJ, Tournay C, Löweberg B, Bolhuis RL et al. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 2001; 98: 1358-1364.
23. Bigby M, Wang P, Fierro JF, Sy MS. Phorbol myristate acetate-induced down-modulation of CD4 is dependent on calmodulin and intracellular calcium. J Immunol 1990; 144: 3111-3116.
24. Luo T, Downing JR, Garcia JV. Induction of phosphorylation of human immunodeficiency virus type 1 Nef and enhancement of CD4 downregulation by phorbol myristate acetate. J Virol 1997; 71: 2535-2539.
25. Rothman KJ. Modern epidemiology. Little, Brown and Company: Boston, 1986.
26. Crippa F, Holmberg L, Carter RA, Hooper H, Marr KA, Bensinger W et al. Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2002; 8: 281-289.
27. Talmadge JE, Reed E, Ino K, Kessinger A, Kuszynski C, Heimann D et al. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant 1997; 19: 161-172.
28. Kalwak K, Gorczynska E, Toporski J, Turkiewicz D, Slociak M, Ussowicz M et al. Immune reconstitution after haematopoietic cell transplantation in children: Immunophenotype analysis with regard to factors affecting the speed of recovery. Br J Haematol 2002; 118: 74-89.
29. Hoepfner S, Haut PR, O'Gorman M, Kletzel M. Rapid immune reconstitution following autologous hematopoietic stem cell transplantation in children: A single institution experience. Bone Marrow Transplant 2003; 31: 285-290.
30. Schlenke P, Sheikhzadeh S, Weber K, Wagner T, Kirchner H. Immune reconstitution and production of intracellular cytokines in T lymphocyte populations following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2001; 28: 251-257.
31. Koehne G, Zeller W, Stockschlaeder M, Zander AR. Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1997; 19: 149-156.
32. Diviné M, Boutolleau D, Delfau-Larue MH, Beaujeau F, Jovault H, Reyes F et al. Poor lymphocyte recovery following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Br J Haematol 1999; 105: 349-360.
33. + cell transplantation. Bone Marrow Transplant 2000; 25: 1249-1255.
34. Singh RK, Varney ML, Buyukberber S, Ino K, Ageitos AG, Reed E et al. Fas-FasL-mediated CD4+ T-cell apoptosis following stem cell transplantation. Cancer Res 1999; 59: 3107-3111.
35. Hakim FT, Cepeda R, Kaimei S, Mackall CL, McAtee N, Zujewski J et al. Constraints on CD4 recovery postchemotherapy in adults: Thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood 1997; 90: 3789-3798.
36. Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM et al. Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 1997; 89: 3700-3707.
37. Singh RK, Varney ML, Ino K, Vose JM, Bierman PJ, Talmadge JE. Immune dysfunction despite high levels of immunoregulatory cytokine gene expression in autologous peripheral blood stem cell transplanted non-Hodgkin's lymphoma patients. Exp Hematol 2000; 28: 499-507.
38. Fagnoni FF, Lozza L, Zibera C, Zambelli A, Ponchio L, Jibelli N et al. Cytotoxic chemotherapy preceding apheresis of peripheral blood progenitor cells can affect the early reconstitution phase of naïve T cells after autologous transplantation. Bone Marrow Transplant 2003; 31: 31-38.
39. Arens R, Baars PA, Jak M, Tesselaar K, Van Der Valk M, Van Oers MH et al. Cutting edge: CD95 maintains effector T cell homeostasis in chronic immune activation. J Immunol 2005; 174: 5915-5920.
40. Porrata LF, Markovic SN. Timely reconstitution of immune competence affects clinical outcome following autologous stem cell transplantation. Clin Exp Med 2004; 4: 78-85.